Thetis Pharmaceuticals is a biopharmaceutical company.
Thetis Pharmaceuticals has raised $9.0M in total funding. The most recent round was Debt Financing. The last funding was announced in January 2025.
Thetis Pharmaceuticals's investors include Connecticut Innovations, Stonehenge Capital, National Institutes of Health, The Leona M. and Harry B. Helmsley Charitable Trust, River Valley Investors.
Thetis Pharmaceuticals is headquartered in Ridgefield, United States.
Thetis Pharmaceuticals is a biopharmaceutical company.
Thetis Pharmaceuticals is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Thetis Pharmaceuticals — Funding & Investors." VCBacked, January 9, 2025, https://www.vcbacked.co/company/thetis-pharmaceuticals. Accessed October 29, 2026.
VCBacked. (2025). Thetis Pharmaceuticals — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/thetis-pharmaceuticals
{{cite web |title=Thetis Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/thetis-pharmaceuticals |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated